» Download Public Reports
27 reports
- Company report
- May 2012
- 3 pages
... To the company S future. If the marketing of bioniche S bladder cancer drug (urocidin ) Is successful, then the shares at current prices are substantially undervalued. For more on bioniche, see e ...
December 2012
... With metastatic bladder cancer, borealis-1, continues to enroll patients throughout the united states, canada and europe. The study aims to enroll approximately 180 patients and is expected to complete patient ...
May 2012
... To the company S future. If the marketing of bioniche S bladder cancer drug (urocidin ) Is successful, then the shares at current prices are substantially undervalued. For more on bioniche, see e ...
November 2012
... Characterized for safety, consistency and potency. Athersys has forged strategic partnerships with pfizer inc. To develop multistem for inflammatory bowel disease and with rti biologics, inc. To develop cell ...
August 2010
... Treatment modalities novo nordisk will expand its leadership by maintaining the world S richest insulin portfolio including new insulin analogues, new insulin formulations and new insulin delivery systems ...
June 2010
... Strong underlying foundation for long term gy partnership in diabetes high diabetes prevalence diabetes complications obesity low insulinization rate public pharma partnership slide no 19514 june ...
October 2010
... Colorectal cancer cardiovascular & metabolism cardiovascular disease diabetes obesity infectious diseases hiv hcv influenza other immunology rheumatoid arthritis psoriasis pulmonary diseases neuroscience ...
November 2010
... hepatitis c drug in late stage clinical development innovation as our core competences our first product launch is the foundation for transformation to pharma strong pipeline and partners swedish biotech ...
September 2012
... Being familiar with the published literature on pca3 testing for prostate cancer Less than 20% reported that the requirement for a digital rectal exam prior to a urine collection would limit ...
June 2012
... N engl j med;366:981- 90. Multiple studies show that early diagnosis is critical to reduce risk of prostate cancer death 38% relative risk reduction at 11y risk of prostate cancer death ...